Clinical Study Results
Research Sponsor: MedImmune LLC
Drug Studied: MEDI7247
Study Title: A study to learn about the safety of MEDI7247 in
participants with cancer of the blood, bone marrow,
or lymph nodes that has regrown or has not
been helped by previous treatment
Thank you
Thank you to the participants who took part in the clinical study for the study
treatment MEDI7247, and to their families. MedImmune, LLC sponsored this
study and believes it is important to share the results. An independent non-profit
organization called CISCRP helped prepare this summary of the study results.
If you or a family member participated in the study and have questions about the
results, please speak with the study doctor or staff at your study site.
1